Stock GMAB GENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Sector consensus Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe
Other stock markets
 16:00:00 09/09/2024 BST 		5-day change 1st Jan Change
1,854.50 DKK -0.30% Intraday chart for Genmab A/S -0.43% -13.62%
01:12pm Truist Lowers Price Target on Genmab to $50 From $53, Maintains Buy Rating MT
09-04 Transcript : Genmab A/S Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 01:05 PM
Main competitors
Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Analyst Opinion 4m Target Price Revision 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Average Target P. Ecart obj. / dr Nbr of analysts
GENMAB A/S Stock Genmab A/S
 2,409.94 +29.57%17
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 1,153.73 +1.96%25
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 509.82 +8.94%29
ARGENX SE Stock argenx SE
 510.75 +4.75%15
BIONTECH SE Stock BioNTech SE
 99.16 +21.71%18
BEIGENE, LTD. Stock BeiGene, Ltd.
 272.96 +42.67%21
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 58.36 +50.41%18
VAXCYTE, INC. Stock Vaxcyte, Inc.
 137.86 +23.55%7
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
 193.59 +50.17%20
INSMED INCORPORATED Stock Insmed Incorporated
 87.50 +23.17%16
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
 168.72 +40.40%25
SUMMIT THERAPEUTICS INC. Stock Summit Therapeutics Inc.
 11.14 +18.87%3
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
 82.93 +71.74%19
ZEALAND PHARMA A/S Stock Zealand Pharma A/S
 1,015.14 +22.60%7
HALOZYME THERAPEUTICS, INC. Stock Halozyme Therapeutics, Inc.
 59.10 -0.19%10
EXELIXIS, INC. Stock Exelixis, Inc.
 27.52 +9.43%21
PHARMAESSENTIA CORPORATION Stock PharmaEssentia Corporation
 856.00 +24.06%4
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
 164.73 +53.51%13
CYTOKINETICS, INCORPORATED Stock Cytokinetics, Incorporated
 81.29 +50.29%17
Average 415.8 +28.82% 16
Weighted average by Cap. 639.68 +16.76% 22
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. Sector Genmab A/S
  5. Sector consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition